Open Congress : Blog Articles for H.R.5629 Pathway for Biosimilars Act

Red or Blue: Weâ€™ll Likely to See Biosimilars Either Way

2008-09-24T00:00:00Z

See also HR 5629: Pathway for Biosimilars Act. The legislation includes standards for the FDA to approve follow-on biologics as well as a period of exclusivity for the brand name drug company. The Act amends section 351 of the Public ...

Go to article

The Pathway for Biosimilars Act - Path or Detour?

2008-09-19T00:00:00Z

With the introduction of the bipartisan Pathway for Biosimilars Act, HR 5629 introduced by Congresswoman Anna Eshoo (D-CA) and committee ranking member Joe Barton (R-TX), many questions have arisen as to whether this proposed ...

Go to article

Biogenerics Would Save How Much?

2008-06-26T00:00:00Z

The bills, by the way, are S. 1695, the Biologics Price Competition and Innovation Act of 2007; HR 1956, the Patient Protection and Innovative Biologic Medicines Act of 2007; and HR 5629, the Pathway for Biosimilars Act. If you go to ...

Go to article

[IHRO] Ariyan Invasion; The Indus Valley Decipherment Hoax ...

2008-06-15T00:00:00Z

1 ((sup)*(/sup), HR 5629, ASI 63.10.371, HU 441; photographed by Erja Lahdenper. Courtesy ASI, Government of India. H-103a, Vol. 1 (*), 2789, ASI 63.11.116, HU 601; photographed by Erja Lahdenper. Courtesy ASI, Government of India. ...

Go to article

Letter: Data Exclusivity a Necessity for Creation of New Biologics

2008-06-11T00:00:00Z

Anna G. Eshoo, D-Calif., and Joe L. Barton, R-Texas, in support of the lawmakersâ€™ legislation that would create an approval pathway for follow-on biologics (HR 5629). The letter highlights the billâ€™s proposed data exclusivity period as ...

Go to article

WALSH CO-SPONSORS BILL TO PROTECT CONSUMERS AND FACILITATE ...

2008-06-04T00:00:00Z

(Washington DC)- Congressman Jim Walsh today announced that he has co-sponsored legislation -- HR 5629, the Pathway for Biosimilars Act -- to hold biosimilars to the same Food and Drug Administration (FDA) approval standards as the ...

Go to article

The Latest from Orange Book Blog

2008-05-22T00:00:00Z

Patent Litigation Under a Future Biosimilars Act. Posted: 21 May 2008 08:17 PM CDT. Biopharmaceuticals, such as EpogenÂ® (epoetin) and ErbituxÂ® (cetuximab), are becoming increasingly important for the treatment of disease. ...

Go to article

Health News from Medical News Today (60 ÑÐ¾Ð¾Ð±Ñ‰ÐµÐ½Ð¸Ð¹)

2008-05-20T00:00:00Z

HSE Warns Employers To Assess Risks Properly After Worker Loses Finger In Unguarded Circular Saw, UK Employers are being warned, by the Health and Safety Executive (HSE), to ensure they assess workplace machinery risks properly to ...

Go to article

Industry Group Letter Indicates Qualified Support For Bill To ...

2008-05-20T00:00:00Z

The Biotechnology Industry Organization has issued a letter to Reps. Anna Eshoo (D-Calif.) and Joe Barton (R-Texas) to indicate qualified support for a bill (HR 5629) that they have introduced to allow FDA to approve generic biotech ...

Go to article

Coalition Releases Letter In Support Of Follow-On Biologics

2008-04-11T00:00:00Z

BIO has drafted its own letter supporting a follow-on biologics bill (HR 5629) proposed by Rep. Anna Eshoo (D-Calif.) and House Energy and Commerce ranking member Joe Barton (R-Texas). According to BIOâ€™s draft letter, the legislationâ€™s ...

Go to article

Proposed Bill Could Pave the Way for the Approval of Biogenerics

2008-04-07T00:00:00Z

HR 5629 is a bipartisan bill called the Pathways for Biosimilars Act. This bill was introduced by Representatives Anna Eshoo (Democrat, California) and Joe Barton (Republican, Texas). This bill provides a way for biosimilars to be ...

Go to article

Patent Docs

2008-03-19T00:00:00Z

The bill (HR 5629), which would amend Section 351 of the Public Health Service Act to create a regulatory pathway for biosimilars, has been referred to the Committee on Energy. ...

Go to article

New Follow-on Biologics Bill Introduced in the House

2008-03-18T00:00:00Z

... at right) introduced a new biologics bill in the House. The bill (HR 5629), which would amend Section 351 of the Public Health Service Act to create a regulatory pathway for biosimilars, has been referred to the Committee on Energy...

Go to article

GPhA opposes HR 5629, biologics bill

2008-03-17T00:00:00Z

Generic Pharmaceutical Association issues statement on HR 5629 biologics bill.

Go to article

Rep. Eshoo Formally Introduces â€œPathway for Biosimilars Act ...

2008-03-16T00:00:00Z

Last Friday, Representatives Anna Eshoo (D-CA) and Joe Barton (R-TX) announced the introduction of HR 5629, the â€œPathway for Biosimilars Act.â€ We previously reported on a draft version of the bill circulated on Capitol Hill in February ...

Go to article